Thc Biomed Intl

(OTC) THCBF

Current Price$0.00

Market CapN/A

Since IPO (2015)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Thc Biomed Intl last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-06-12

Thc Biomed Intl stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-05-19
1 month	+0%	USD 0.00	2026-05-13
3 month	+0%	USD 0.00	2026-01-14
Year to date	+0%	USD 0.00	2025-12-30
1 year	+0%	USD 0.00	2025-02-10
3 year	-100%	USD 0.03	2023-06-13
5 year	-100%	USD 0.11	2021-06-11
Since inception	-100%	USD 0.05	2015-08-31

Thc Biomed Intl Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$2.86M

Net Income (TTM)

-CA$3.67M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

270.57 (High)

Dividend

$0.00

Beta (Volatility)

270.57 (High)

Price

$0.00

Volume

10,297

Open

$0.00

Price

$0.00

Volume

10,297

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jul 3, 2026

Dividend

$0.00

Beta (Volatility)

270.57 (High)

Price

$0.00

Volume

10,297

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jul 3, 2026

THCBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Thc Biomed Intl

THC Biomed Intl Ltd. is a Canadian company focused on the production and sale of cannabis products for medical and recreational use. Established in 2012 and headquartered in Kelowna, the company offers a variety of cannabis-infused edibles and drinks, including gummies and beverage shots under the THC KISS brand.

Products and Services

Cannabis-infused edibles, including gummies and biscuits
THC KISS beverage shots for recreational consumers
Standalone pure cannabis sticks for medical use

Growth Outlook

Recent quarterly revenue showed a decline, indicating potential challenges
Inventory levels remain high, suggesting a need for improved sales strategies
Market demand for cannabis products continues to grow, presenting future opportunities

Financial Highlights

Latest quarterly revenue of CAD 476,230, down from CAD 817,096
Net income for Q3 2023 was CAD -935,212, reflecting ongoing operational losses
Cash and cash equivalents increased to CAD 205,015, indicating liquidity management efforts

THC Biomed Intl Ltd. operates in the competitive cannabis industry, which has seen significant growth in recent years. However, the company faces challenges, as evidenced by declining revenues and ongoing net losses. The high inventory levels may require strategic adjustments to enhance sales performance. Despite these hurdles, the overall market demand for cannabis products remains robust, suggesting potential for future growth. Investors may find interest in the company's innovative product offerings and its established presence in the cannabis sector.

AI Generated • Jun 25, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

John Miller

Website

www.thcbiomed.com

Headquarters

Kelowna, BC V1X 7L4, CA

THCBF Financials

Key Financial Metrics (TTM)

Gross Margin

-30.83%

Operating Margin

-95.89%

Net Income Margin

-91.79%

Return on Equity

-36.68%

Return on Capital

-30.50%

Return on Assets

-20.79%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

10.30K

Avg. Volume

540.371

Financials (TTM)

Gross Profit

-CA$1.16M

Operating Income

-CA$3.05M

EBITDA

-CA$2.03M

Operating Cash Flow

-CA$503.46K

Capital Expenditure

-CA$232.15K

Free Cash Flow

-CA$735.61K

Cash & ST Invst.

CA$205.02K

Total Debt

CA$2.59M

Thc Biomed Intl Performance Analysis

Thc Biomed Intl annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-07-31	CAD 2,960,570	N/A
2022	2022-07-31	CAD 2,631,673	-11.1%

Thc Biomed Intl sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-07-31	28.4%
Q1	2022-10-31	-25.6%
Q2	2023-01-31	22.3%
Q3	2023-04-30	-41.7%

Thc Biomed Intl annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-07-31	CAD -0.03	N/A
2022	2022-07-31	CAD -0.01	-51.8%

Thc Biomed Intl sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-07-31	-975.0%
Q1	2022-10-31	76.7%
Q2	2023-01-31	-205.0%
Q3	2023-04-30	6.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

CA$476.23K

-31.9%

Gross Profit

-CA$370.40K

-84.5%

Gross Margin

-77.78%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-CA$935.21K

-613.3%

EBITDA

-CA$585.40K

-402.1%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

CA$205.02K

-82.3%

Total Debt

CA$2.59M

-14.0%

Accounts Receivable

CA$109.11K

-76.4%

Inventory

CA$2.55M

-22.3%

Long Term Debt

CA$975.26K

-49.4%

Short Term Debt

CA$1.61M

+49.1%

Return on Assets

-20.79%

N/A

Return on Invested Capital

-40.53%

N/A

Free Cash Flow

CA$38.56K

+106.0%

Operating Cash Flow

CA$38.91K

+108.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVTBFAvant Brands Inc.

AVTBFAvant Brands Inc.$0.41+5.38%

BBRRFBlueberries Medical Corp.

BBRRFBlueberries Medical Corp.$0.01+0.00%

PCLOFPharmaCielo Ltd.

PCLOFPharmaCielo Ltd.$0.04+0.38%

CANNTrees Corporation

CANNTrees Corporation$0.03-7.17%

MVMDFMountain Valley MD Holdings Inc.

MVMDFMountain Valley MD Holdings Inc.$0.06+0.00%

RVVQFRavenQuest BioMed Inc.

RVVQFRavenQuest BioMed Inc.$0.00+0.00%

BUDZWEED, Inc.

BUDZWEED, Inc.$0.03-0.59%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ZYBTZhengye Biotechnology

ZYBTZhengye Biotechnology$8.01+10.48%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.14+0.01%

ACHRArcher Aviation

ACHRArcher Aviation$5.31+0.20%

IRENIren

IRENIren$40.20+0.20%

HLHecla Mining

HLHecla Mining$14.29-0.00%

TAT&T

TAT&T$21.95+0.01%

NOKNokia

NOKNokia$10.08-0.00%

Questions About THCBF

What is the current price of Thc Biomed Intl?

Thc Biomed Intl is trading at $0.00 per share.

What is the 52-week range for Thc Biomed Intl?

Over the past 52 weeks, Thc Biomed Intl has traded between $0.00 and $0.00.

How much debt does Thc Biomed Intl have?

As of the most recent reporting period, Thc Biomed Intl reported total debt of CA$3.50M.

How much cash does Thc Biomed Intl have on hand?

Thc Biomed Intl reported CA$377.79K in cash and cash equivalents in its most recent financial results.

What is Thc Biomed Intl’s dividend yield?

Thc Biomed Intl does not currently have a dividend yield.

Thc Biomed Intl

Thc Biomed Intl Financials at a Glance

THCBF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Thc Biomed Intl

THCBF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Thc Biomed Intl Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About THCBF

What is the current price of Thc Biomed Intl?

What is the 52-week range for Thc Biomed Intl?

How much debt does Thc Biomed Intl have?

How much cash does Thc Biomed Intl have on hand?

What is Thc Biomed Intl’s dividend yield?

Premium Investing Services